VERENIUM CORPORATION SUBSTITUTE AWARD AGREEMENTSubstitute Award Agreement • September 23rd, 2013 • Verenium Corp • Industrial organic chemicals • Delaware
THIS SUBSTITUTE AWARD AGREEMENT (“Agreement”) entered into as of the 19th day of September, 2013, by and among VERENIUM CORPORATION, a Delaware corporation (the “Company”), BASF CORPORATION, a Delaware corporation (“Parent”) and [ ] (the “Executive”). Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Merger Agreement (as defined below).
12/27/2017 Converted RSUs Award Agreement - ReviewSubstitute Award Agreement • February 12th, 2018 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
This Substitute Award Agreement (this “Agreement”) is made effective as of August 2nd, 2016, between Teva Pharmaceutical Industries Limited (the “Company”) and Hafrun Fridriksdottir (the “Participant”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned thereto in the Company’s 2015 Long-Term Equity-Based Incentive Plan (the “Plan”).
12/27/2017 Options Award Agreement—ReviewSubstitute Award Agreement • February 12th, 2018 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
This Substitute Award Agreement (this “Agreement”) is made effective as of August 2nd, 2016, between Teva Pharmaceutical Industries Limited (the “Company”) and Hafrun Fridriksdottir (the “Participant”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned thereto in the Company’s 2015 Long-Term Equity-Based Incentive Plan (the “Plan”).
